Effect of captopril and losartan on blood pressure and accumulation of LDL and fibrinogen by aortic wall and other tissues in normotensive and hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 1, 1997, Pages 125-129

  Medina, R ^a   Cardona Sanclemente, L E ^a   Born, G V R ^a   Brown, M J ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Accumulation; ACE inhibitors; Angiotensin II receptor I antagonists; Blood pressure; Fibrinogen; Low density lipoprotein (LDL)

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; LOSARTAN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HYPERTENSION; LIPID METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CAPTOPRIL; FIBRINOGEN; HYPERTENSION; IMIDAZOLES; LIPOPROTEINS, LDL; LOSARTAN; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0031022446     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199701000-00019     Document Type: Article

References (22)

1. MacMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized trials. Prog Cardiovasc Dis 1986;29(suppl 1):99-118.
2. Shafi S, Cusak NJ, Born GVR. Increased uptake of methylated low density lipoprotein induced by noradrenaline in carotid arteries of anaesthetised rabbits. Proc R Soc Med 1989;235:289-98.
3. Cardona-Sanclemente LE, Born GVR. Adrenaline increases the uptake of low-density lipoproteins in carotid arteries of rabbits. Atherosclerosis 1992;96:215-8.
4. Cardona-Sanclemente LE, Born GVR. Increased uptake of fibrinogen into arterial walls of unrestrained conscious rats caused by adrenaline and angiotensin II [Abstract]. Br J Pharmacol 1992; 107:317P.
5. Cardona-Sanclemente LE, Medina R, Born GVR. Effect of increasing concentrations of angiotensin II infused into unrestrained conscious rats on LDL and fibrinogen uptake by aorta [Abstract]. Br J Pharmacol 1994;111:22P.
6. Medina R, Cardona-Sanclemente LE, Born GVR. Effect of angiotensin II and losartan on the incorporation of human and rat low density lipoproteins by organs of normotensive and hypertensive rats [Abstract]. Eur Heart J 1995;16:274.
7. Cardona-Sanclemente LE, Medina R, Born GVR. Effect of increasing doses of angiotensin II infused into normal and hypertensive rats on low density lipoprotein and fibrinogen uptake by aortic walls. Proc Natl Acad Sci U S A 1994;91:3285-8.
8. Chobanian AV Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effects of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990;15:327-31.
9. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 1990;15(suppl 5):S65-72.
10. Chiu AT, McCall DE, Price WA, et al. In vitro pharmacology of DuP 753, a nonpeptide All receptor antagonist. Am J Hypertens 1991;4(2):282-7S.
11. Wong PC, Price WA Jr, Chiu AT, et al. Hypotensive action of DuP 753, an angiotensin antagonist, in spontaneously hypertensive rats nonpeptide angiotensin II receptor antagonists: X. Hypertension 1990;15:459-69.
12. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45(2):205-51.
13. Christ DD, Kilkson T, Wong N, Lam G. Formation and disposition of EXP3174, a pharmacologically active metabolite of the novel angiotensin II receptor antagonist DuP 753. Presented at the International Society for the Study of Xenobiotica (ISSX), San Diego, CA, Oct. 21-25, 1990.
14. Koppers D, Hauswirth O. Captopril, fosinopril and fosinoprilate prolong the action potential duration in rabbit Purkinje fibres. Naunyn-Schmiedebergs Arch Pharmacol 1992;345(suppl 1):R78.
15. Havel RJ, Edner HA, Bragdon J. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
16. Koga S, Horwitz DL, Scanu AM. Isolation and properties of lipoproteins from normal rat serum. J Lipid Res 1969;10:577-88.
17. Pittman RC, Carew TE, Glass CK, Taylor CA, Attie AD. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J 1983;212: 791-800.
18. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 1990;66:22-32D.
19. Sudhir K, MacGregor JS, Gupta M, et al. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Circulation 1993;87:931-8.
20. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993;91:1453-8.
21. Wilson SK. Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res 1990;66:722-34.
22. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-7.